ArticleFrontiers in medicine2026
Application of atopic dermatitis control tool (ADCT) for daily practice in a community-based dermatology clinic.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a relapsing and remitting course. It is important to maintain remission over the long term in order to preserve patients' quality of life and achieve treatment goals. To identify the status of long-term control, the application of patient-reported outcome measures (PROMs) is useful. We applied the Atopic Dermatitis Control Tool (ADCT) to our everyday practice. ADCT is a holistic scale with 6-items covering multiple aspects of disease control. Between July and December 2021, all the patients with AD over the age of 12 years who visited our clinic were evaluated using the ADCT and Investigator's Global Assessment (IGA) on each visit. A total of 238 patients (mean age 34.4+/-14.5 years old; 63% male) completed the ADCT. In total, 568 sets of measurements were obtained. The average ADCT score was 7.8+/-4.9, and the ADCT score significantly correlated with that of the IGA. 62.9% of patients were categorized as having good control (ADCT score < 7) at least once during the study period. The ADCT score of those who regularly visited was 6.5+/-3.9 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.